American Journal of Pediatrics

| Peer-Reviewed |

Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting

Received: Feb. 07, 2020    Accepted: Feb. 20, 2020    Published: Mar. 06, 2020
Views:       Downloads:

Share This Article

Abstract

Background: Neurocysticercosis is a helminthiasis of public health interest in developing countries, where it is potentially responsible for 70% of epilepsy cases. Clinical presentations are diverse and depend on central nervous system localization of the parasite. The diagnosis is based on a number of factors including environmental context, clinical presentation, radiological imaging and serology. The treatment is often medical, with surgery being left for specific cases. Holistic prevention involves prophylaxis, treatment of asymptomatic carriers and reinforcement of health education. Method: We report a case of neurocysticercosis being responsible for a curable form of epilepsy in a Cameroonian child living in the urban community of Yaoundé. The patient was treated exclusively by medical means involving curative and symptomatic medications over a period of 21 days. Results: By the end of the treatment, the patient clinically recovered, though some residual latent cerebral sequels persisted. Conclusion: Neurocysticercosis may be found in children living in urban communities, causing neuropsychic disorders among which epilepsy. Prompt diagnosis may be aided by cerebral radiological imaging such as CT-scan or MRI. The management may be exclusively medical with complete recovery. However, primary prevention is a relevant intervention that may be done by proper disposal of human and animal faeces, rigorous hygiene, effective meat cooking before consumption, health education and prophylaxis with anthelmintics.

DOI 10.11648/j.ajp.20200602.14
Published in American Journal of Pediatrics ( Volume 6, Issue 2, June 2020 )
Page(s) 91-93
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Cysticercosis, Neurocysticercosis, Epilepsy, Cameroon

References
[1] Lagueste M: La neurocysticercose humaine en 2015: etude retrospective de 4 cas pris en charge au CHU de Rouen de 2011 à 2015. Thesis. Université de Rouen 2015; 122p.
[2] Singhi P, Singhi S. Neurocysticercosis in children. J Child Neurol, 2004; 19: 92-482.
[3] Scott J X, Devia A et al. A rare presentation of neurocysticercosis in a young child. J Trop Pediatr, 2005; 51: 5-254.
[4] Castillo H. imaging of neurocysticercosis. Semin Roentgenol, 2004; 39: 73-465.
[5] Del Brutto O H, Garcia H H. Neurocysticercosis in non endemic countries: time for a reappraisal. Neuroepidemioogy, 2012; 39: 145-6.
[6] Zoli A D, Nguemkam et al. Neurocysticercosis and epilepsy in Cameroon. Trans R Soc Trop Med Hyg, 2003; 97 (6): 683-6.
[7] Coyle C, Wittner M et al. Tropical infectious diseases: principles, pathogens and practice. Philadephia: Churchill Livingstone Guerant R, Walker D Weller P, editors 1999.
[8] Ramirez-Bernudez J, Higuera J et al. Is dementia reversible in patients with neurocysticercosis. J Neurol Psychiatr, 2005; 76: 1164-6.
[9] Neurocysticercosis in sub-saharan Africa: a review of prevalence, clinical characteristics, diagnosis and management. Technical University of munich, Bavaria, Germany.
[10] Diagana M, Nsengiyumva G. Electroencephalogrammes réalisées chez 250 patients dans une zone d’endemie cysticerquienne au Burundi. Neurophysiol Clin, 2005; 35: 1-10.
[11] Zhao S, Xu K. Changes in computed tomogram in cerebral parenchyma cysticercosis treated with albendazole. Zhon Ch Xue Jsh Ch Bi Z Zhi 1999; 390-3.
[12] Talukdar B, Saxena A et al. neurocysticercosis in children: clinical characteristics and outcome. Am Trop Pediatr 2002; 22: 333-9.
[13] Aguilar-Rebollero F, Meza-Lucas A et al. Evaluation of enzyme linked immunoelectrotransfer blot essay for diagnostic of neurocysticercosis in children. J Child Neurol, 2002; 17: 20-4016.
[14] Agrawal S, Ranjam S et al. Ocular myocysticercosis: an unusual case of ptosis. Nepal J Ophtalmo, 2013; 5: 81-279.
[15] Garcia H H, Gonzales I et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazol for neurocysticercosis: a double–blind randomized controlled trial. Lancet Infect Dis, 2014; 14: 687-95.
Cite This Article
  • APA Style

    Georges Pius Kamsu Moyo, Audrey Thérese Mbang, Laura Kuate Makowa, Raïssa Monayong Mendomo, Sonia Zebaze, et al. (2020). Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting. American Journal of Pediatrics, 6(2), 91-93. https://doi.org/10.11648/j.ajp.20200602.14

    Copy | Download

    ACS Style

    Georges Pius Kamsu Moyo; Audrey Thérese Mbang; Laura Kuate Makowa; Raïssa Monayong Mendomo; Sonia Zebaze, et al. Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting. Am. J. Pediatr. 2020, 6(2), 91-93. doi: 10.11648/j.ajp.20200602.14

    Copy | Download

    AMA Style

    Georges Pius Kamsu Moyo, Audrey Thérese Mbang, Laura Kuate Makowa, Raïssa Monayong Mendomo, Sonia Zebaze, et al. Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting. Am J Pediatr. 2020;6(2):91-93. doi: 10.11648/j.ajp.20200602.14

    Copy | Download

  • @article{10.11648/j.ajp.20200602.14,
      author = {Georges Pius Kamsu Moyo and Audrey Thérese Mbang and Laura Kuate Makowa and Raïssa Monayong Mendomo and Sonia Zebaze and Hubert Désiré Mbassi Awa},
      title = {Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting},
      journal = {American Journal of Pediatrics},
      volume = {6},
      number = {2},
      pages = {91-93},
      doi = {10.11648/j.ajp.20200602.14},
      url = {https://doi.org/10.11648/j.ajp.20200602.14},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.ajp.20200602.14},
      abstract = {Background: Neurocysticercosis is a helminthiasis of public health interest in developing countries, where it is potentially responsible for 70% of epilepsy cases. Clinical presentations are diverse and depend on central nervous system localization of the parasite. The diagnosis is based on a number of factors including environmental context, clinical presentation, radiological imaging and serology. The treatment is often medical, with surgery being left for specific cases. Holistic prevention involves prophylaxis, treatment of asymptomatic carriers and reinforcement of health education. Method: We report a case of neurocysticercosis being responsible for a curable form of epilepsy in a Cameroonian child living in the urban community of Yaoundé. The patient was treated exclusively by medical means involving curative and symptomatic medications over a period of 21 days. Results: By the end of the treatment, the patient clinically recovered, though some residual latent cerebral sequels persisted. Conclusion: Neurocysticercosis may be found in children living in urban communities, causing neuropsychic disorders among which epilepsy. Prompt diagnosis may be aided by cerebral radiological imaging such as CT-scan or MRI. The management may be exclusively medical with complete recovery. However, primary prevention is a relevant intervention that may be done by proper disposal of human and animal faeces, rigorous hygiene, effective meat cooking before consumption, health education and prophylaxis with anthelmintics.},
     year = {2020}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Neurocysticercosis in a Child Living in the Urban Community of Yaoundé, Cameroon: A Case Report in a Low Resource Setting
    AU  - Georges Pius Kamsu Moyo
    AU  - Audrey Thérese Mbang
    AU  - Laura Kuate Makowa
    AU  - Raïssa Monayong Mendomo
    AU  - Sonia Zebaze
    AU  - Hubert Désiré Mbassi Awa
    Y1  - 2020/03/06
    PY  - 2020
    N1  - https://doi.org/10.11648/j.ajp.20200602.14
    DO  - 10.11648/j.ajp.20200602.14
    T2  - American Journal of Pediatrics
    JF  - American Journal of Pediatrics
    JO  - American Journal of Pediatrics
    SP  - 91
    EP  - 93
    PB  - Science Publishing Group
    SN  - 2472-0909
    UR  - https://doi.org/10.11648/j.ajp.20200602.14
    AB  - Background: Neurocysticercosis is a helminthiasis of public health interest in developing countries, where it is potentially responsible for 70% of epilepsy cases. Clinical presentations are diverse and depend on central nervous system localization of the parasite. The diagnosis is based on a number of factors including environmental context, clinical presentation, radiological imaging and serology. The treatment is often medical, with surgery being left for specific cases. Holistic prevention involves prophylaxis, treatment of asymptomatic carriers and reinforcement of health education. Method: We report a case of neurocysticercosis being responsible for a curable form of epilepsy in a Cameroonian child living in the urban community of Yaoundé. The patient was treated exclusively by medical means involving curative and symptomatic medications over a period of 21 days. Results: By the end of the treatment, the patient clinically recovered, though some residual latent cerebral sequels persisted. Conclusion: Neurocysticercosis may be found in children living in urban communities, causing neuropsychic disorders among which epilepsy. Prompt diagnosis may be aided by cerebral radiological imaging such as CT-scan or MRI. The management may be exclusively medical with complete recovery. However, primary prevention is a relevant intervention that may be done by proper disposal of human and animal faeces, rigorous hygiene, effective meat cooking before consumption, health education and prophylaxis with anthelmintics.
    VL  - 6
    IS  - 2
    ER  - 

    Copy | Download

Author Information
  • Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

  • Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

  • Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

  • Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

  • Department of Paediatrics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Cameroon

  • Section